• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中心脏性猝死的风险分层

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.

作者信息

Miller Marc A, Gomes J Anthony, Fuster Valentin

机构信息

Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Nat Clin Pract Cardiovasc Med. 2007 Dec;4(12):667-76. doi: 10.1038/ncpcardio1057.

DOI:10.1038/ncpcardio1057
PMID:18033231
Abstract

Hypertrophic cardiomyopathy (HCM) is the most common hereditary cardiac condition and the leading cause of sudden cardiac death (SCD) in young adults. Given that SCD can be the first and most devastating clinical expression of HCM, identifying individuals at high risk is paramount. Determining an individual's risk for HCM-related SCD requires a thorough understanding of the recognized risk factors, of which there are seven established or 'major' and five 'possible'. Major risk factors can be identified by thoroughly reviewing a patient's personal medical history and noninvasive cardiovascular testing. The presence of major risk factors identify patients who are at high enough risk of SCD to warrant consideration of an implantable cardioverter-defibrillator; whereas the absence of any major risk factors provides considerable reassurance to both patient and physician. The risk of HCM-related SCD in patients with no major risk factors is, however, not zero. Possible risk factors gain importance in the presence of an isolated major risk factor. Here, we provide a contemporary review of established and possible risk factors for HCM-related SCD. We also examine microvolt T-wave alternans and cardiovascular MRI as emerging risk stratification tools that could further hone our ability to accurately identify the high-risk patient.

摘要

肥厚型心肌病(HCM)是最常见的遗传性心脏疾病,也是年轻成年人心脏性猝死(SCD)的主要原因。鉴于SCD可能是HCM的首发且最具毁灭性的临床表现,识别高危个体至关重要。确定个体发生HCM相关SCD的风险需要全面了解已公认的风险因素,其中有七个已确定的或“主要”风险因素以及五个“可能”风险因素。通过全面回顾患者的个人病史和无创心血管检查可以识别主要风险因素。主要风险因素的存在可确定SCD风险足够高、值得考虑植入式心脏复律除颤器的患者;而不存在任何主要风险因素则可让患者和医生都相当安心。然而,没有主要风险因素的患者发生HCM相关SCD的风险并非为零。在存在单一主要风险因素的情况下,可能风险因素就变得重要起来。在此,我们对已确定的和可能的HCM相关SCD风险因素进行当代综述。我们还探讨了微伏级T波交替和心血管磁共振成像作为新兴的风险分层工具,它们可能进一步提高我们准确识别高危患者的能力。

相似文献

1
Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.肥厚型心肌病中心脏性猝死的风险分层
Nat Clin Pract Cardiovasc Med. 2007 Dec;4(12):667-76. doi: 10.1038/ncpcardio1057.
2
[Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].[肥厚型心肌病猝死风险评估]
Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73.
3
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者对比增强磁共振成像延迟钆增强的特征及临床意义。
Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.
4
Hypertrophic cardiomyopathy--state of the art in 2007.
Rev Port Cardiol. 2008 May;27(5):625-37.
5
Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.儿童孤立性肥厚型心肌病的危险因素及死亡方式
J Am Coll Cardiol. 2009 Jul 14;54(3):250-4. doi: 10.1016/j.jacc.2009.03.051.
6
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.一项对 2003 年美国心脏病学会/欧洲心脏病学会和 2011 年美国心脏病学会基金会/美国心脏协会用于肥厚型心肌病患者心源性猝死风险分层和治疗算法的验证研究。
Heart. 2013 Apr;99(8):534-41. doi: 10.1136/heartjnl-2012-303271. Epub 2013 Jan 22.
7
Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.微伏级T波电交替在预测心肌病患者心源性猝死中的应用价值。
Curr Opin Cardiol. 2007 Jan;22(1):25-32. doi: 10.1097/HCO.0b013e328011aa49.
8
[Cardiomyopathies. VIII. Sudden death in hypertrophic cardiomyopathy].
Rev Esp Cardiol. 1996 Apr;49(4):288-304.
9
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.无症状肥厚型心肌病突变携带者的心脏性猝死疾病外显率和风险分层。
Eur Heart J. 2009 Nov;30(21):2593-8. doi: 10.1093/eurheartj/ehp306. Epub 2009 Aug 6.
10
Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.一名患有肥厚型心肌病且无典型危险因素的年轻患者发生心脏骤停:肥厚型心肌病风险分层的内在局限性
Congenit Heart Dis. 2014 Mar-Apr;9(2):E51-7. doi: 10.1111/chd.12073. Epub 2013 May 7.

引用本文的文献

1
Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart.利用心脏瘢痕的深度学习分析进行心律失常性猝死生存预测
Nat Cardiovasc Res. 2022 Apr;1(4):334-343. doi: 10.1038/s44161-022-00041-9. Epub 2022 Apr 7.
2
HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.心脏节律学会政策声明:临床心脏电生理专科培训课程:2011年更新
Heart Rhythm. 2011 Aug;8(8):1340-56. doi: 10.1016/j.hrthm.2011.06.008. Epub 2011 Jun 14.
3
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
肥厚型心肌病的研究重点:美国国立心肺血液研究所工作组报告
Circulation. 2010 Sep 14;122(11):1130-3. doi: 10.1161/CIRCULATIONAHA.110.950089.
4
Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy.在肥厚型心肌病的早期检测和预后中不断发展的解剖、功能和分子影像学。
J Cardiovasc Transl Res. 2009 Dec;2(4):398-406. doi: 10.1007/s12265-009-9133-6. Epub 2009 Oct 16.
5
The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.肥厚型心肌病的多面性:从发育生物学到临床实践。
J Cardiovasc Transl Res. 2009 Dec;2(4):349-67. doi: 10.1007/s12265-009-9137-2. Epub 2009 Oct 27.
6
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.肥厚型心肌病患者心脏性猝死的危险分层:荷兰心脏病学家与突变携带者的护理。
Neth Heart J. 2009 Dec;17(12):464-9. doi: 10.1007/BF03086305.
7
Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress.老年心脏在氧化应激期间对心室颤动的易感性增加。
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1594-605. doi: 10.1152/ajpheart.00579.2009. Epub 2009 Sep 18.
8
Therapeutic options in hypertrophic cardiomyopathy: a pediatric perspective.肥厚型心肌病的治疗选择:儿科视角
Curr Treat Options Cardiovasc Med. 2008 Sep;10(5):433-41. doi: 10.1007/s11936-008-0035-8.